“In Vivo Delivery of Nucleic Acid-Formulated Microparticles As a Potential Tolerogenic Vaccine for Type 1 Diabetes ”. The Review of Diabetic Studies 9, no. 4 (August 12, 2023). Accessed January 19, 2026. https://www.diabeticstudies.org/index.php/RDS/article/view/184.